Risperidone Safety and Efficacy in the Treatment of Bipolar and Schizoaffective Disorders
The Journal of Clinical PsychiatryPublished 15 October 2001
Eduard Vieta, José Manuel Goikolea, Bàrbara Corbella, Antonio Benabarre, María Reinares, G. Martínez
Citations123
SJR quartileQ1
SJR score1.49
SNIP1.38
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
This large study provides additional evidence that risperidone is effective and well tolerated when combined with mood stabilizers in the treatment of bipolar disorder and schizoaffective disorder, bipolar type.
Abstract
This large study provides additional evidence that risperidone is effective and well tolerated when combined with mood stabilizers in the treatment of bipolar disorder and schizoaffective disorder, bipolar type. Previous concerns about exacerbation of manic symptoms were not confirmed.
Keywords
ChemistryMedicine